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Basic Science Articles
Acid-Base Status Determines the Renal Expression of Ca2
and Mg2 Transport Proteins
Tom Nijenhuis, Kirsten Y. Renkema, Joost G.J. Hoenderop, and Rene´ J.M. Bindels
Department of Physiology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre,
Nijmegen, The Netherlands
Chronic metabolic acidosis results in renal Ca2 and Mg2wasting, whereas chronic metabolic alkalosis is known to exert the
reverse effects. It was hypothesized that these adaptations are mediated at least in part by the renal Ca2 and Mg2 transport
proteins. The aim of this study, therefore, was to determine the effect of systemic acid-base status on renal expression of the
epithelial Ca2 channel TRPV5, the Ca2-binding protein calbindin-D28K, and the epithelial Mg
2 channel TRPM6 in relation
to Ca2 and Mg2 excretion. Chronic metabolic acidosis that was induced by NH4Cl loading or administration of the carbonic
anhydrase inhibitor acetazolamide for 6 d enhanced calciuresis accompanied by decreased renal TRPV5 and calbindin-D28K
mRNA and protein abundance in wild-type mice. In contrast, metabolic acidosis did not affect Ca2 excretion in TRPV5
knockout (TRPV5/) mice, in which active Ca2 reabsorption is effectively abolished. This demonstrates that downregula-
tion of renal Ca2 transport proteins is responsible for the hypercalciuria. Conversely, chronic metabolic alkalosis that was
induced by NaHCO3 administration for 6 d increased the expression of Ca
2 transport proteins accompanied by diminished
urine Ca2 excretion in wild-type mice. However, this Ca2-sparing action persisted in TRPV5/ mice, suggesting that
additional mechanisms apart from upregulation of active Ca2 transport contribute to the hypocalciuria. Furthermore, chronic
metabolic acidosis decreased renal TRPM6 expression, increased Mg2 excretion, and decreased serum Mg2 concentration,
whereas chronic metabolic alkalosis resulted in the exact opposite effects. In conclusion, these data suggest that regulation of
Ca2 and Mg2 transport proteins contributes importantly to the effects of acid-base status on renal divalent handling.
J Am Soc Nephrol 17: 617–626, 2006. doi: 10.1681/ASN.2005070732
A cid-base homeostasis is known to affect renal han-dling of the divalents Ca2 and Mg2 (1–3). Chronicmetabolic acidosis, which can occur as a result of
clinical disorders such as renal failure, distal renal tubular
acidosis, or chronic diarrhea, is associated with increased renal
Ca2 and Mg2 excretion. Long-standing metabolic acidosis
can lead to Ca2 loss from bone and ultimately results in
metabolic bone disease, including osteomalacia and osteoporo-
sis (4). Conversely, chronic metabolic alkalosis in, for example,
the milk-alkali syndrome, volume contraction, or treatment of
nephrolithiasis by bicarbonate supplementation is known to
decrease urine Ca2 and Mg2 excretion (1,3). However, the
molecular mechanisms that explain the altered renal divalent
excretion during these disturbances of acid-base balance re-
main unknown.
The major part of Ca2 and Mg2 reabsorption takes place in
the proximal tubule and thick ascending limb of the loop of
Henle (TAL) through a passive paracellular pathway (1,3).
Fine-tuning of divalent excretion by the kidney occurs in the
distal convoluted tubule (DCT) and the connecting tubule
(CNT). In the latter segments, active transcellular Ca2 and
Mg2 reabsorption determines the final amount excreted into
the urine. Active Ca2 reabsorption consists of Ca2 entry
through the apically localized epithelial Ca2 channel TRPV5,
cytosolic transport bound to the calcium-binding and buffering
protein calbindin-D28K, and basolateral extrusion by the Na
/
Ca2 exchanger (NCX1) and a plasma membrane Ca2 ATPase
(PMCA1b) (1,5,6). Studying the regulation of active Mg2 re-
absorption in DCT has been seriously hampered by the lack of
identification of the proteins involved (3). TRPM6 was recently
identified as a Mg2 permeable channel predominantly ex-
pressed along the apical membrane of DCT (7). Mutations in
TRPM6 cause autosomal recessive hypomagnesemia, character-
ized by inappropriately high fractional Mg2 excretion rates
and disturbed intestinal Mg2 absorption (8,9). This clearly
suggests that TRPM6 constitutes the apical entry step in active
Mg2 (re)absorption and thus provides an important new tool
to study this process at the molecular level (7).
Earlier studies, including micropuncture experiments, sug-
gested that systemic acid-base disturbances specifically influ-
ence Ca2 and Mg2 reabsorption in DCT/CNT (2,10). Hypo-
thetically, regulation of Ca2 and Mg2 transport proteins in
these nephron segments could be involved in the altered renal
divalent excretion secondary to changes in acid-base status, as
was shown for other renal transporters and channels (11–14).
We previously demonstrated that tacrolimus (FK506)-induced
Ca2 and Mg2 wasting as well as thiazide-induced hypomag-
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nesemia are associated with decreased renal expression of Ca2
and/or Mg2 transporters (15,16). Recently, TRPV5 knockout
(TRPV5/) mice were generated in our laboratory, which
display a robust renal Ca2 leak localized to DCT/CNT, illus-
trating that active Ca2 reabsorption is effectively abolished
(17). These mice constitute a unique mouse model to determine
the role of TRPV5 and active Ca2 reabsorption in acid-base
induced alterations of calciuresis.
The aim of this study, therefore, was to determine the effect
of chronic metabolic acidosis and alkalosis on the expression of
Ca2 and Mg2 transporters in the kidney and to evaluate their
contribution to the altered Ca2 and Mg2 excretion. We in-
duced metabolic alkalosis by oral NaHCO3 loading and meta-
bolic acidosis by NH4Cl loading, as well as applied acetazol-
amide administration in wild-type and TRPV5/ mice.
Acetazolamide specifically inhibits proximal tubular HCO3 re-
absorption, resulting in a self-limiting metabolic acidosis with,
in contrast to NH4Cl loading, an alkaline urine pH (18–20). This
enabled evaluation of the role of luminal pH. Furthermore,
whereas acidosis generally increases urine Mg2 excretion, ac-
etazolamide is known for its unexplained Mg2-sparing action
(21–23).
Materials and Methods
Metabolic Acidosis and Alkalosis in Wild-Type and
TRPV5/ Mice
Metabolic Acidosis. TRPV5/ mice were recently generated by
targeted ablation of the TRPV5 gene and genotyped as described pre-
viously (17). Ten-week-old wild-type (TRPV5/) mice and TRPV5/
littermates were kept in a light- and temperature-controlled room with
ad libitum access to deionized drinking water. Mice were ration-fed
standard pelleted chow (0.25% [wt/wt] NaCl, 1.1% [wt/wt] Ca, 0.2%
[wt/wt] Mg) during the metabolic balance studies. For evaluation of
the effects of metabolic acidosis, mice were randomly assigned to a
group that received either 0.28 M (TRPV5/) or 0.14 M (TRPV5/)
NH4Cl via the drinking water during 6 d or a control group that
received normal deionized drinking water. NH4Cl loading is a gener-
ally accepted and validated method to induce metabolic acidosis in
rodents (11–13,24). Because the oral fluid intake of TRPV5/ mice is
approximately two-fold higher than that in wild-type mice, the lower
NH4Cl concentration in their drinking water ensured a similar oral acid
load compared with wild-type mice to prevent acid overloading in
these TRPV5/ mice. Alternatively, subcutaneous administration of
the carbonic anhydrase inhibitor acetazolamide (20 mg/kg per d) dur-
ing 6 d by osmotic minipumps was applied. This enabled evaluation of
the role of urine pH in metabolic acidosis-induced changes in Ca2
excretion as well as the role of TRPM6 in the unexplainedMg2-sparing
action of acetazolamide.
Metabolic Alkalosis. Metabolic alkalosis was induced by oral ad-
ministration of 0.2 and 0.1 M NaHCO3 to TRPV5
/ and TRPV5/
mice, respectively. NaHCO3 loading was previously shown to induce
metabolic alkalosis in rodents (12,13). Mice that received 0.2 or 0.1 M
NaCl constituted the control group, thereby correcting for possible
effects of the increased Na load. The latter is particularly important
because passive Ca2 reabsorption is functionally coupled to Na
reabsorption. Mice were treated for 6 d, after which they were housed
in metabolic cages to enable collection of 24-h urine samples under
mineral oil, preventing evaporation. At the end of the experiment, the
mice were killed, blood samples were taken, and kidneys were sam-
pled. The animal ethics board of the Radboud University Nijmegen
approved all animal studies.
Analytical Procedures
Serum and urine Ca2 and Mg2 concentrations were determined
using colorimetric assays as described previously (16,25). Blood gas
measurements were performed using a Hitachi auto-analyzer (Hitachi,
Laval, Quebec, Canada). Na, K, and Li concentrations were mea-
sured flame-spectrophotometrically (Eppendorf FCM 6343, Hamburg,
Germany). Urine pH was determined using an electronic ion analyzer
(Hanna Instruments, Szeged, Hungary), and osmolarity was measured
with an Osmette A automatic osmometer (Precision Instruments, Sud-
bury, MA).
Real-Time Quantitative PCR
Total RNA was extracted from kidney using TriZol Total RNA
Isolation Reagent (Life Technologies BRL, Breda, The Netherlands). The
obtained RNA was subjected to DNAse treatment and reverse tran-
scribed using Molony-Murine Leukemia Virus-Reverse Transcriptase
(Life Technologies BRL) as described previously (26,27). Subsequently,
the acquired cDNA was used to determine TRPV5, calbindin-D28K, and
TRPM6 mRNA levels in kidney by real-time quantitative PCR on an
ABI Prism 7700 Sequence Detection System (PE Biosystems, Rotkreuz,
Switzerland) as described previously (15,26). In addition, mRNA ex-
pression of the housekeeping gene hypoxanthine-guanine phosphori-
bosyl transferase was determined as an endogenous control, which
enabled calculation of specific mRNA expression levels as a ratio of
hypoxanthine-guanine phosphoribosyl transferase.
Immunohistochemistry
Staining of kidney sections for TRPV5, calbindin-D28K, and TRPM6
was performed on cryosections of periodate-lysine-paraformaldehyde–
fixed kidney samples as described previously (7,28). For semiquantita-
tive determination of protein abundance, images were made using a
Zeiss fluorescence microscope equipped with a digital camera (Nikon
DXM1200), which were analyzed with the Image Pro Plus 4.1 image
analysis software (Media Cybernetics, Silver Spring, MD). The entire
cortex in two separate kidney sections of each animal was included in
the analysis, resulting in quantification of protein levels as the mean of
integrated optical density.
Immunoblotting
Calbindin-D28K protein levels were semiquantified by immunoblot-
ting as described previously (27). In short, kidney cortex sections were
homogenized and samples were normalized according to protein con-
centration. Subsequently, protein samples were separated on 16.5%
(wt/vol) SDS-PAGE gels and blotted to polyvinylidene difluoride–
nitrocellulose membranes (Immunobilon-P; Millipore Corp., Bedford,
MA), and protein was detected using a rabbit calbindin-D28K antibody.
Statistical Analyses
Data are expressed as means  SEM. Statistical comparisons were
analyzed by one-way ANOVA and Fisher multiple comparison. P 
0.05 was considered statistically significant. All analyses were per-
formed using the StatView Statistical Package software (Power PC
version 4.51, Berkely, CA) on an Apple iMac computer.
Results
Metabolic Acidosis and Alkalosis in Wild-Type and
TRPV5/ Mice
Oral NH4Cl loading induced a similar metabolic acidosis in
wild-type and TRPV5/ mice, as demonstrated by the signif-
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icantly reduced blood pH and HCO3
 concentration (Table 1).
Accordingly, NH4Cl reduced urine pH in wild-type and
TRPV5/mice compared with their respective controls (Table
2). Likewise, chronic acetazolamide treatment significantly in-
creased urine pH and decreased blood pH and HCO3
 concen-
tration in wild-type but not in TRPV5/ mice. Of note, aceta-
zolamide-induced acidosis and urinary alkalinization is often
self-limiting. Indeed, urine pH was more alkaline in all animals
after 3 d compared with day 6 of treatment (data not shown).
Furthermore, blood gas determination substantiated the effec-
tiveness of the oral NaHCO3 loading protocol in wild-type and
TRPV5/ mice. Serum pH was similar in both genotypes
during NaHCO3 loading, whereas serum HCO3
 levels in
TRPV5/ mice were significantly higher. This reflects higher
pCO2 in the latter situation, most probably as a result of dif-
ferences in time or depth of anesthesia. The absence of this
difference in pCO2 between wild-type and TRPV5
/ mice in
the other treatment groups suggests that there is no intrinsic
increased susceptibility to retain CO2 in TRPV5
/ mice. It is
interesting that urine pH was consistently 0.5 to 1 pH unit
lower in TRPV5/ mice as compared with the corresponding
wild-type mice, but, importantly, TRPV5/ mice did not dis-
play metabolic acidosis at baseline. Diuresis and Na excretion
were not affected by NH4Cl or NaHCO3 loading, whereas
Table 1. Acid-base status during different treatment protocols in TRPV5/ and TRPV5/ micea
TRPV5/ TRPV5/
pH HCO3

(mM) pH
HCO3

(mM)
Controls 7.27 0.01 22.3 0.7 7.26 0.03 21.0 0.5
NH4Cl 7.11 0.05
b 17.2 1.3b 7.16 0.01b 18.3 0.7b
ACTZ 7.22 0.02b 19.0 0.9b 7.22 0.01 23.1 0.9
NaCl 7.27 0.02 22.6 0.8 7.25 0.02 21.7 0.5
NaHCO3 7.35 0.01
b,c 25.8 1.0b,c 7.35 0.01b,c 36.3 3.8b,c
aControls, animals that received deionized drinking water only; NH4Cl, animals that received 0.28 (TRPV5
/) or 0.14 M
(TRPV5/) NH4Cl via the drinking water; ACTZ, animals that received acetazolamide (20 mg/kg per d) subcutaneously by
osmotic minipump; NaCl, animals that received 0.2 (TRPV5/) or 0.1 M (TRPV5/) NaCl via the drinking water; NaHCO3,
animals that received 0.2 (TRPV5/) or 0.1 M (TRPV5/) NaHCO3 via the drinking water. Data are presented as means 
SEM.
bP  0.05 versus respective TRPV5/ or TRPV5/ controls.
cP  0.05 versus respective TRPV5/ or TRPV5/ NaCl-treated mice.
Table 2. Urine composition and fluid intake during chronic metabolic acidosis and alkalosis in TRPV5/ and
TRPV5/ micea
pH Urine Volume(mL/24 h)
Na Excretion
(mmol/24 h)
K Excretion
(mmol/24 h)
Li Clearance
(L/min)
Urine Osmolarity
(mOsmol/kg)
Fluid Intake
(mL/24 h)
TRPV5/
controls 7.0 0.2 5.3 1.4 0.4 0.1 1.4 0.1 13 1 2434 175 16.9 3.8
NH4Cl 6.0 0.1
b 5.1 0.7 0.5 0.1 1.2 0.1 11  1 2710 246 12.1 0.3
ACTZ 8.3 0.1b 9.7 0.9b 0.7 0.2b 1.9 0.3b 19 3b 1720 64b 20.4 2.5
NaCl 7.5 0.2 17.1 1.7b 3.6 0.3b 1.4 0.1 30 2b 1484 52b 26.7 4.8
NaHCO3 8.8 0.1
b,c 10.8 3.3b 1.6 0.2b,c 1.0 0.1c 17 3b,c 1540 146b 27.4 2.4
TRPV5/
controls 6.0 0.1 18.7 2.4 0.5 0.1 1.5 0.1 16 2 1113 101 30.6 3.3
NH4Cl 5.4 0.1
b 15.8 1.7 0.5 0.1 1.3 0.2 13 2 1488 99 26.4 4.1
ACTZ 7.4 0.2b 33.1 4.0b 0.9 0.1b 2.3 0.1b 19 1b 709 28b 44.6 4.8
NaCl 6.1 0.1 23.6 2.2b 3.1 0.5b 1.4 0.1 25 2b 1000 30 29.4 7.5
NaHCO3 8.3 0.1
b,c 18.6 5.7 1.3 0.1b,c 0.6 0.1b,c 11 2b,c 1036 90 37.1 1.1
aControls, animals that received deionized drinking water only; NH4Cl, animals that received 0.28 (TRPV5
/) or 0.14 M
(TRPV5/) NH4Cl via the drinking water; ACTZ, animals that received acetazolamide (20 mg/kg per d) subcutaneously by
osmotic minipump; NaCl, animals that received 0.2 (TRPV5/) or 0.1 M (TRPV5/) NaCl via the drinking water; NaHCO3,
animals that received 0.2 (TRPV5/) or 0.1 M (TRPV5/) NaHCO3 via the drinking water; n  9 animals per treatment
group; n  3 animals per cage. Data are presented as means  SEM.
bP  0.05 versus respective TRPV5/ or TRPV5/ controls.
cP  0.05 versus respective TRPV5/ or TRPV5/ NaCl-treated mice.
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acetazolamide significantly increased urine volume and natri-
uresis in wild-type and TRPV5/ mice (Table 2).
Ca2 Homeostasis during Chronic Metabolic Acidosis
and Alkalosis
Genetic ablation of TRPV5 resulted in a strikingly increased
calciuresis compared with wild-type littermates (Figure 1A).
NH4Cl loading significantly enhanced urine Ca
2 excretion in
wild-type mice, whereas Ca2 excretion was not affected in
TRPV5/ mice. Likewise, acetazolamide treatment signifi-
cantly enhanced calciuresis in wild-type mice, whereas this
effect was not present in TRPV5/ mice. Serum Ca2 levels
remained unaltered during NH4Cl loading and acetazolamide
treatment (Figure 1C). In contrast to metabolic acidosis,
NaHCO3 administration significantly reduced urine Ca
2 ex-
cretion in wild-type as well as in TRPV5/ mice (Figure 1B).
Serum Ca2 levels and urine volume did not differ between the
alkalosis and control groups (Figure 1D, Table 1). Because Li
and Na are transported in parallel by the proximal tubule,
endogenous Li clearance was used as an inverse measure of
proximal tubular Na reabsorption, to which in turn passive
Ca2 reabsorption is functionally coupled (16). Li clearance
was significantly increased by acetazolamide treatment and
NaCl loading in wild-type and TRPV5/ mice, suggesting
decreased proximal tubular Na reabsorption (Table 1). Con-
versely, NaHCO3 loading decreased Li
 clearance compared
with NaCl-treated controls.
Mg2 Homeostasis during Chronic Metabolic Acidosis
and Alkalosis
In addition, we evaluated the effect of the different treatment
protocols on renal Mg2 homeostasis in wild-type mice. Oral
NH4Cl loading significantly enhanced Mg
2 excretion (Figure
2A), which was accompanied by decreased serum Mg2 levels
(Figure 2C). In contrast, acetazolamide displayed a Mg2-sparing
effect accompanied by a significantly increased serum Mg2 con-
centration. Likewise, metabolic alkalosis that was induced by
NaHCO3 treatment significantly reduced urine Mg
2 excretion
(Figure 2B) and increased the serum Mg2 level (Figure 2D).
Renal mRNA and Protein Expression of Ca2 Transporters
For studying the effect of systemic acid-base status on renal
Ca2 transporter expression, TRPV5 and calbindin-D28K
mRNA levels were determined by real-time quantitative PCR
analysis, and protein abundance was analyzed by immunohis-
tochemistry and immunoblotting. NH4Cl loading significantly
reduced both TRPV5 and calbindin-D28K mRNA levels in kid-
ney cortex of wild-type mice (Figure 3, A and C). Calbindin-
D28K mRNA levels were significantly decreased in TRPV5
/
compared with TRPV5/ mice. In addition, NH4Cl treatment
further reduced calbindin-D28K mRNA levels compared with
control TRPV5/ mice. Figure 4A shows representative
immunohistochemical images of kidney cortex probed with
anti-TRPV5 and anti–calbindin-D28K antibodies. In addition,
calbindin-D28K protein abundance was determined by immu-
noblotting (Figure 4B). In line with the mRNA levels, semi-
quantification of the immunohistochemical analysis showed
that NH4Cl decreases TRPV5 and calbindin-D28K protein abun-
dance (Figure 5, A and C). These results were confirmed by
immunoblotting (100  4 versus 63  9% in wild-type and
100  5 versus 75  8% in TRPV5/ mice, respectively).
Acetazolamide treatment decreased TRPV5 mRNA and protein
expression in wild-type mice (Figures 3A and 5A). Further-
more, calbindin-D28K protein abundance was reduced in aceta-
zolamide-treated mice (Figure 5C), as confirmed by immuno-
blotting (100  1 versus 63  6 and 40  8% in wild-type and
TRPV5/ mice, respectively). In contrast to metabolic acido-
sis, chronic metabolic alkalosis that was induced by NaHCO3
loading increased TRPV5 mRNA and protein expression in
wild-type mice (Figures 3B and 5B). Likewise, calbindin-D28K
expression was increased as determined by real-time PCR and
immunohistochemistry (Figures 3D and 5D), as well as by
Figure 1. Urinary Ca2 excretion and serum Ca2 concentration
during metabolic acidosis and alkalosis in wild-type
(TRPV5/) and TRPV5 knockout (TRPV5/) mice. The ef-
fects of chronic metabolic acidosis and acetazolamide (A) as
well as during metabolic alkalosis (B) on renal Ca2 excretion
and serum Ca2 concentration (C and D) were determined in
metabolic cage experiments (n  9 animals; n  3 animals per
cage). Controls, animals that received deionized drinking water
only; NH4Cl, animals that received 0.28 M (TRPV5
/) or 0.14
M (TRPV5/) NH4Cl via the drinking water; Acetazolamide,
animals that received acetazolamide (20 mg/kg per d) subcu-
taneously by osmotic minipump; NaCl, animals that received
0.2 (TRPV5/) or 0.1 M (TRPV5/) NaCl via the drinking
water; NaHCO3, animals that received 0.2 (TRPV5
/) or 0.1 M
(TRPV5/) NaHCO3 via the drinking water. Data are pre-
sented as means  SEM. *P  0.05 versus respective TRPV5/
or TRPV5/ control group (controls or NaCl-treated animals).
620 Journal of the American Society of Nephrology J Am Soc Nephrol 17: 617–626, 2006
immunoblotting (100  41 versus 293  40%). Conversely,
calbindin-D28K mRNA and protein levels were not significantly
increased in NaHCO3-treated TRPV5
/ mice.
Effect of Acid-Base Status on Renal TRPM6 Expression
Renal TRPM6mRNA and protein expression levels were deter-
mined by real-time quantitative PCR analysis (Figure 6) and semi-
quantitative immunohistochemistry (Figure 7A). Both NH4Cl
loading and acetazolamide treatment significantly reduced renal
TRPM6 mRNA as well as protein abundance in wild-type mice
(Figures 6A and 7B), whereas NaHCO3-treated mice displayed
increased TRPM6 expression (Figures 6B and 7C).
Discussion
This study demonstrated that systemic acid-base status reg-
ulates the expression of proteins that are involved in active
Ca2 andMg2 reabsorption. Our data showed that downregu-
lation of renal Ca2 transport proteins is responsible for the
hypercalciuria during chronic metabolic acidosis. In contrast,
the Ca2-sparing effect of chronic metabolic alkalosis was as-
sociated with enhanced Ca2 transporter abundance. However,
the Ca2-sparing action persisted in TRPV5/ mice, suggest-
ing that additional mechanisms apart from upregulation of
active Ca2 transport contribute to the hypocalciuria. Further-
Figure 2. Urinary Mg2 excretion and serum Mg2 concentra-
tion during metabolic acidosis and alkalosis in wild-type mice.
The effects of chronic metabolic acidosis and acetazolamide (A)
as well as during metabolic alkalosis (B) on renal Mg2 excre-
tion and serumMg2 concentration (C and D) were determined
in metabolic cage experiments (n  9 animals; n  3 animals
per cage). Controls, animals that received deionized drinking
water only; NH4Cl, animals that received 0.28 M NH4Cl via the
drinking water; Acetazolamide, animals that received acetazol-
amide (20 mg/kg per d) subcutaneously by osmotic minipump;
NaCl, animals that received 0.2 M NaCl via the drinking water;
NaHCO3, animals that received 0.2 MNaHCO3 via the drinking
water. Data are presented as means  SEM. *P  0.05 versus
respective control group (controls or NaCl-treated animals).
Figure 3. Effect of chronicmetabolic acidosis and alkalosis on renal
mRNA expression of Ca2 transport proteins in TRPV5/ and
TRPV5/ mice. Renal mRNA expression levels of the epithelial
Ca2 channel TRPV5 and the cytosolic Ca2-binding protein cal-
bindin-D28K (CaBP28K) were determined during chronic metabolic
acidosis and acetazolamide treatment (A and C, respectively) and
chronic metabolic alkalosis (B and D, respectively) by real-time
quantitative PCR analysis as the ratio of hypoxanthine-guanine
phosphoribosyl transferase (HPRT) and depicted as percentage of
respective controls. Controls, animals that received deionized
drinking water only; NH4Cl, animals that received 0.28
(TRPV5/) or 0.14M (TRPV5/) NH4Cl via the drinkingwater;
Acetazolamide, animals that received acetazolamide (20 mg/kg
per d) subcutaneously by osmotic minipump; NaCl, animals that
received 0.2 (TRPV5/) or 0.1 M (TRPV5/) NaCl via the
drinking water; NaHCO3, animals that received 0.2 (TRPV5
/)
or 0.1 M (TRPV5/) NaHCO3 via the drinking water; n  9
animals per group. Data are presented as means SEM. *P 0.05
versus respective TRPV5/ or TRPV5/ control group (controls
or NaCl-treated animals); #P  0.05 versus TRPV5/ controls.
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more, metabolic acidosis decreased renal TRPM6 abundance as
well as Mg2 reabsorption, whereas metabolic alkalosis had the
opposite effect. These data indicate that regulation of TRPM6
explains the effects of acid-base status on renal Mg2 handling.
Chronic metabolic acidosis that was induced by NH4Cl load-
ing enhanced Ca2 excretion and decreased the expression of
the epithelial Ca2 channel TRPV5 and the cytosolic Ca2-
binding and buffering protein calbindin-D28K in wild-type
mice. Both proteins play a central role in active Ca2 reabsorp-
tion in DCT/CNT (1). We showed that 0.14 M NH4Cl loading
induced a similar metabolic acidosis in polydipsic TRPV5/
mice compared with wild-type mice. Importantly, Ca2 excre-
tion was not altered during chronic metabolic acidosis in
TRPV5/ mice, in which active Ca2 reabsorption is effec-
tively abolished (17). These results indicated that downregula-
tion of Ca2 transport proteins that are present in DCT/CNT
underlies the increased Ca2 excretion during NH4Cl loading.
Alternatively, increased Ca2 mobilization from bone has been
shown in chronic metabolic acidosis and was suggested to
explain the Ca2 wasting (4,29). Our study provides evidence
for a primary renal Ca2 leak. In line with our data, previous
micropuncture experiments suggested that tubular Ca2 reab-
sorption in DCT/CNT is specifically diminished during chronic
metabolic acidosis in dogs (2). In contrast, Rizzo et al. (30)
previously reported that NH4Cl-induced acidosis in rats was
accompanied by a moderate although significant increase of
calbindin-D28K. The reason for the discrepancy with our study,
which shows a consistent decrease of TRPV5 and calbindin-
D28K mRNA as well as protein expression, is not known.
Mice that receive NH4Cl develop chronic metabolic acidosis
that is characterized by a slight decrease in blood pH, a reduced
serumHCO3
 concentration, and, importantly, a low urine pH as
substantiated in this study (24). Vennekens et al. (31) recently
demonstrated that extracellular protons inhibit TRPV5 in vitro by
titrating glutamate 522 in the extracellular loop between the fifth
putative transmembrane domain and the pore region as shown by
Yeh et al. (32). Therefore, it was suggested that acidification of the
DCT/CNT luminal fluid during chronic metabolic acidosis ex-
plains the decreased Ca2 reabsorption in vivo (31,32). These data
raised the question of whether the regulation of Ca2 transport
proteins is secondary to the acidosis per se or due to the low urine
pH. This urine acidification has been attributed mainly to parallel
enhancement of apical Na/H exchanger (NHE3) and basolat-
eral Na-HCO3
 co-transporter activity in the proximal tubule
(33–36). In contrast, acetazolamide treatment is known to induce
metabolic acidosis by diminishing this proximal tubular HCO3

reabsorptive capacity (18–20). This would result in an increased
luminal pH at more distal nephron segments, including TRPV5
and calbindin-D28K–expressing DCT/CNT. In our study, acetazo-
lamide-treated mice indeed displayed urine alkalinization. Impor-
tantly, acetazolamide downregulated the expression of Ca2
transport proteins. Thus, luminal pH in DCT/CNT does not seem
to be crucial in the long-term in vivo hypercalciuric effect of
chronic metabolic acidosis. Therefore, our data provide a molec-
ular explanation for the increased Ca2 excretion in clinically
relevant situations, including chronic renal failure, chronic diar-
rhea, and renal tubular acidosis. In particular, acetazolamide treat-
ment is a common cause of proximal renal tubular acidosis and is
Figure 4. Immunohistochemical staining and semiquantitative immunoblotting of renal Ca2 transport proteins in TRPV5/
mice. (A) Representative immunohistochemical images of TRPV5 and CaBP28K staining in kidney cortex of wild-type mice. (B)
Representative immunoblots for calbindin-D28K. Controls, animals that received deionized drinking water only; NH4Cl, animals
that received 0.28 M NH4Cl via the drinking water; ACTZ, animals that received acetazolamide (20 mg/kg per d) subcutaneously
by osmotic minipump; NaCl, animals that received 0.2 M NaCl via the drinking water; NaHCO3, animals that received 0.2 M
NaHCO3 via the drinking water.
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often associated with Ca2 nephrolithiasis (37,38). Taken together,
we showed that systemic metabolic acidosis, as opposed to asso-
ciated changes in urine pH, downregulates Ca2 transport pro-
teins and, thereby, induces hypercalciuria.
Conversely, chronic metabolic alkalosis is known to decrease
Ca2 excretion (2). In this study, chronic NaHCO3 administra-
tion induced metabolic alkalosis in wild-type as well as
TRPV5/ mice. Chronic metabolic alkalosis had a Ca2-spar-
ing effect and increased renal expression of the Ca2 transport
proteins in wild-type mice. This suggests that the increased
expression of these transporters is responsible for the hypocal-
ciuric effect. However, TRPV5 ablation resulting in the func-
tional lack of active Ca2 transport did not preclude this effect,
suggesting that upregulation of Ca2 transport proteins in
DCT/CNT is not crucial for the induction of hypocalciuria. It is
interesting that alkalosis did not enhance calbindin-D28K abun-
dance in TRPV5/ mice. This is in line with previous studies
from our laboratory, which demonstrated that blockade of the
TRPV5-mediated Ca2 influx in rabbit CNT/CCD cells down-
regulates calbindin-D28K expression (39). This indicated that
regulation of the latter protein is highly dependent on the
presence of TRPV5. The bulk of filtered Ca2 is reabsorbed by
a passive paracellular mechanism that is localized primarily in
the proximal tubule and to a lesser extent in TAL (1). In these
nephron segments, Ca2 reabsorption is secondary to Na
reabsorption and the resulting water reabsorption, which cre-
ates a favorable electrochemical gradient driving passive Ca2
transport. Determination of Li clearance indeed suggested
that NaHCO3-treated mice show increased proximal tubular
Na reabsorption and, therefore, possibly display enhanced
Figure 5. Effect of chronicmetabolic acidosis and alkalosis on renal
protein abundance of Ca2 transport proteins in TRPV5/ and
TRPV5/ mice. Renal protein expression levels of the epithelial
Ca2 channel TRPV5 and the cytosolic CaBP28K were determined
during chronicmetabolic acidosis and acetazolamide treatment (A
and C, respectively) as well as chronic metabolic alkalosis (B and
D, respectively) by computerized analysis of immunohistochem-
ical images. Data were calculated as integrated optical density
(IOD; arbitrary units) and depicted as percentage of respective
controls. Controls, animals that received deionized drinkingwater
only; NH4Cl, animals that received 0.28 (TRPV5
/) or 0.14 M
(TRPV5/) NH4Cl via the drinking water; Acetazolamide, ani-
mals that received acetazolamide (20 mg/kg per d) subcutane-
ously by osmotic minipump; NaCl, animals that received 0.2
(TRPV5/) or 0.1 M (TRPV5/) NaCl via the drinking water;
NaHCO3, animals that received 0.2 (TRPV5
/) or 0.1 M
(TRPV5/) NaHCO3 via the drinking water; n  9 animals per
treatment group. Data are presented as means  SEM. *P  0.05
versus respective TRPV5/ or TRPV5/ control group (controls
or NaCl-treated animals); #P  0.05 versus TRPV5/ controls.
Figure 6. Effect of chronic metabolic acidosis and alkalosis on
renal mRNA expression of the epithelial Mg2 channel TRPM6
in wild-type mice. Renal mRNA expression levels of TRPM6
was determined during chronic metabolic acidosis and acet-
azolamide treatment (A) as well as chronic metabolic alkalosis
(B) by real-time quantitative PCR analysis as the ratio of HPRT
and depicted as percentage of respective controls. Controls,
animals that received deionized drinking water only; NH4Cl,
animals that received 0.28 M NH4Cl via the drinking water;
Acetazolamide, animals that received acetazolamide (20 mg/kg
per d) subcutaneously by osmotic minipump; NaCl, animals
that received 0.2 M NaCl via the drinking water; NaHCO3,
animals that received 0.2 M NaHCO3 via the drinking water;
n  9 animals per treatment group. Data are presented as
means  SEM. *P  0.05 versus respective control group (con-
trols or NaCl-treated animals).
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passive Ca2 reabsorption compared with NaCl-treated con-
trols. Thus, the hypocalciuria could alternatively be explained
by increased passive Ca2 reabsorption. Taken together, the
present data offer insight into the previously unexplained
mechanism by which administration of HCO3
 prevents neph-
rolithiasis in patients with recurrent kidney stones (40,41). Up-
regulation of Ca2 transport proteins in DCT/CNT occurs but
is not crucial for the Ca2-sparing effect.
The epithelial Mg2 channel TRPM6 is the first identified
protein involved in active Mg2 reabsorption (7–9). TRPM6
was localized along the apical membrane of DCT, and muta-
tions in the gene encoding TRPM6 were shown to cause auto-
somal recessive hypomagnesemia, characterized by inappro-
priately high Mg2 excretion and disturbed intestinal Mg2
absorption. In our study, NH4Cl-induced chronic metabolic
acidosis decreased renal TRPM6 abundance accompanied by
increased Mg2 excretion and hypomagnesemia. Conversely,
chronic metabolic alkalosis increased TRPM6 expression as
well as renal Mg2 reabsorption, resulting in hypermag-
nesemia. There is insufficient functional information available
regarding the tubular segments that are involved in the altered
Mg2 reabsorption, but Wong et al. (10,42) previously demon-
strated altered Mg2 reabsorption in the distal tubule during
metabolic acidosis and alkalosis in the dog. Furthermore, a high
extracellular pH was shown to enhance Mg2 uptake in iso-
lated mouse DCT cells, and conversely a low pH diminished
this uptake (43). Thus, these data suggest that alterations of
acid-base status regulate TRPM6 expression, thereby affecting
renal active Mg2 reabsorption in DCT and leading to signifi-
cant changes in serum Mg2. We previously demonstrated that
thiazide administration as well as treatment with the hypomag-
nesemic immunosuppressant tacrolimus (FK506) reduces renal
TRPM6 abundance accompanied by increased urine Mg2 loss
(15,16). Therefore, TRPM6 downregulation seems to be a gen-
eral mechanism explaining the renal Mg2 leak and resulting
hypomagnesemia in these important clinical situations.
It is interesting that we showed that acetazolamide displays
a Mg2-sparing effect in mice. This carbonic anhydrase inhib-
itor is also known to result in hypomagnesuria in human via an
unknown mechanism (21–23). Importantly, TRPM6 expression
was significantly diminished during chronic acetazolamide
treatment. This suggests that chronic metabolic acidosis, irre-
spective of cause or associated urine pH, downregulates
TRPM6 expression. At the same time, these data are against
enhanced active Mg2 reabsorption explaining the decreased
Mg2 excretion. In contrast to Ca2, the bulk of filtered Mg2
is reabsorbed in TAL, where the Na-K(NH4
)-2Cl
(NKCC2) cotransporter is responsible for maintaining the re-
quired electrochemical gradient (44). Acetazolamide treatment
was associated with increased urine volume and Na excretion,
which has been shown to result in extracellular volume con-
traction and enhanced NKCC2 activity (45,46). Furthermore,
metabolic acidosis, which developed in acetazolamide-treated
wild-type mice, was previously shown to increase NKCC2
mRNA and protein abundance (14,47). Thus, we postulate that
these additive stimulatory effects enhance passive Mg2 reab-
sorption in TAL. Alternatively, regulation of the tight junction
protein paracellin-1, which is supposed to facilitate paracellular
reabsorption of Mg2 in TAL, might be involved (48,49). To-
gether, these mechanisms could counteract the metabolic aci-
Figure 7. Effects of chronic metabolic acidosis and alkalosis on
renal protein abundance of the epithelial Mg2 channel TRPM6
in wild-type mice. Representative immunohistochemical imag-
ing of TRPM6 staining in kidney cortex (A), which enabled
semiquantitative determination of renal TRPM6 protein abun-
dance during chronic metabolic acidosis and acetazolamide
treatment (B) as well as chronic metabolic alkalosis (C) by
computerized analysis. Data were calculated as IOD (arbitrary
units) and depicted as percentage of respective controls. Con-
trols, animals that received deionized drinking water only;
NH4Cl, animals that received 0.28 M NH4Cl via the drinking
water; ACTZ/Acetazolamide, animals that received acetazol-
amide (20 mg/kg per d) subcutaneously by osmotic minipump;
NaCl, animals that received 0.2 M NaCl via the drinking water;
NaHCO3, animals that received 0.2 MNaHCO3 via the drinking
water; n  9 animals per treatment group. Data are presented
as means  SEM. *P  0.05 versus respective control group
(controls or NaCl-treated animals).
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dosis-induced TRPM6 downregulation and result in a net
Mg2-sparing effect.
The mechanism translating the acid-base status to regulation
of gene expression remains largely unknown. Our results show
that transcriptional regulation occurs irrespective of urine pH.
Because intracellular pH will ultimately reflect pH of the urine,
apical or intracellular acid sensing does not seem to be in-
volved. Therefore, direct sensing of acid-base status by pH-
sensitive proteins at the basolateral membrane is likely. In
DCT/CNT, the extracellular Ca2/Mg2-sensing receptor is
expressed at the basolateral membrane (50,51). It was shown
recently that extracellular pH directly influences the sensitivity
of this receptor to Ca2 and Mg2 (52,53). Therefore, altered
Ca2/Mg2 sensing might influence transcellular divalent
transport in these nephron segments. Furthermore, other baso-
lateral proton-sensing receptors or channels might act as an
acid sensor regulating Ca2 and Mg2 transport protein ex-
pression (54,55). Thus, whereas the presented data demon-
strated the transcriptional and translational regulation of pro-
teins that are involved in active Ca2 and Mg2 reabsorption,
future studies will have to elucidate the exact mechanism by
which acid-base status affects expression of these transporters.
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